Bayer welcomes call for new trial in $2 billion glyphosate-based weedkiller case

Published On 2019-07-20 03:30 GMT   |   Update On 2019-07-20 03:30 GMT

Bayer had asked Judge Smith in June to overrule the jury verdict that its Roundup weedkiller caused the couple's non-Hodgkin's Lymphoma (NHL), arguing the decision was not supported by the evidence.


FRANKFURT: Germany's Bayer AG on Friday welcomed a conditional ruling by a U.S. judge calling for a retrial of the case of a couple awarded $2 billion in damages by a jury who found that its glyphosate-based weedkiller caused their cancer.


Shares in Bayer were up 1.4% in early Frankfurt trade.


Judge Winifred Y. Smith, of California's Alameda County Superior Court, ruled that the case of Alva and Alberta Pilliod should be retried, citing misconduct by a lawyer for the plaintiff and concerns around the scale of damages awarded.


"The court's tentative order proposes changes in the damage awards, which would be a step in the right direction," Bayer said in a statement. "Bayer will wait for a final order on the post-trial motions before commenting in further detail."


Bayer attached a copy of the court ruling to its statement.


Bayer had asked Judge Smith in June to overrule the jury verdict that its Roundup weedkiller caused the couple's non-Hodgkin's Lymphoma (NHL), arguing the decision was not supported by the evidence.


The German drugmaker and chemicals company said in court filings at the time that the massive verdict was based on "inflammatory, fabricated and irrelevant evidence" from the couple's lawyers.


Read Also: City council reviews use of Bayer Roundup weed killer amid cancer fears

Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News